EGF and pancreatic neoplasm: To determine whether this is also true in pancreatic tumor, we treated three different types of PDAC cells (L3.6, BxPC3, and DanG) with EGF, and then analyzed the cell lysates using an antibody specifically recognizing Y639-phosphorylated (pY639) PIPKIγ [5].